( RICS:ORMP )

News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 29, 2013, 07:40 ET Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems of drugs currently administered by...


Apr 22, 2013, 09:15 ET Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that the Company's CEO...


Apr 18, 2013, 03:21 ET Oramed Pharmaceuticals Chosen to Present at the 5th International Congress on Prediabetes and the Metabolic Syndrome in Vienna, Austria; April 18-20, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that its abstract,...


Apr 16, 2013, 09:15 ET Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, today announced a key addition to...


Apr 11, 2013, 03:11 ET Oramed Submits New IND Application for Oral Insulin Trial in the US

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...


Apr 03, 2013, 07:45 ET Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...


Mar 21, 2013, 09:15 ET Oramed Pharmaceuticals Selected to Present at the 73rd Scientific Sessions of the American Diabetes Association in Chicago, IL, June 21-25, 2013

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...


Feb 18, 2013, 09:15 ET Oramed Pharmaceuticals to Present at the 4th Annual Drug Delivery & Formulation Summit in Berlin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr. Ehud Arbit,...


Feb 14, 2013, 09:27 ET Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been in...


Feb 11, 2013, 09:45 ET Oramed Pharmaceuticals Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that their February...


Feb 07, 2013, 08:30 ET Shares of Oramed Pharmaceuticals Are Approved for Listing on the Nasdaq Capital Market

Oramed Pharmaceuticals Inc. (OTCQB: ORMPD), a developer of oral drug delivery systems, announced today that NASDAQ has approved the company's...


Feb 05, 2013, 07:00 ET Oramed Pharmaceuticals Inc. to Webcast, Live, at RetailInvestorConferences.com on February 7th

Oramed Pharmaceuticals Inc. (OTC:ORMPD) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Nadav Kidron,...


Jan 22, 2013, 16:30 ET Oramed Pharmaceuticals Announces Reverse Stock Split

Oramed Pharmaceuticals Inc. (OTCQB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its previously...


Jan 07, 2013, 09:20 ET Oramed Pharmaceuticals Files Investigational New Drug Application with the FDA for Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has filed...


Dec 11, 2012, 09:20 ET Oramed Pharmaceuticals Completes $5.6 Million Funding to Advance Clinical Trials

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has completed...


Nov 07, 2012, 09:20 ET Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012

Oramed Pharmaceuticals Inc. (OTCBB: ORMP; www.oramed.com), a developer of oral delivery systems, announced today that results of a study performed...


Oct 18, 2012, 09:20 ET Former Johnson & Johnson and Bausch & Lomb Executive, Gerald Ostrov, Joins Oramed Pharmaceuticals' Board of Directors

Oramed Pharmaceuticals Inc. (OTCBB:ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that Gerald Ostrov,...


Oct 03, 2012, 09:20 ET Oramed Pharmaceuticals to Collaborate With Leading Contract Research Organization Medpace for Phase II FDA Trial on Oral Insulin

Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its...


Jul 11, 2012, 09:20 ET Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins

Announcing its third patent approval since the beginning of the calendar year, Oramed Pharmaceuticals Inc. (OTCBB:ORMP.OB) (www . oramed . com), a...


May 29, 2012, 09:26 ET Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has...